Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Pancreatitis Clinical Trials
Pancreatitis clinical trials are recruiting across 40 cities. Here are the cities with the most active studies:
Pancreatitis Trial Phases
24 research organizations are sponsoring pancreatitis trials.
About Pancreatitis
Pancreatitis is inflammation of the pancreas that can be acute or chronic, often caused by gallstones or heavy alcohol use. Chronic pancreatitis leads to progressive damage and impaired function. Treatment includes pain management, enzyme replacement, dietary changes, and treating underlying causes.
Clinical trials are advancing new treatments for pancreatitis. Currently, 37 studies are recruiting a combined 15,111 participants across the United States. Research is being conducted by 24 organizations including Johns Hopkins University, M.D. Anderson Cancer Center, University of Kansas Medical Center and 21 others.
2026 Pancreatitis Research Landscape
As of July 2026, the pancreatitis clinical trial landscape includes 37 actively recruiting studies across 40 cities in the United States. These studies are collectively seeking 15,111 participants, with an average enrollment target of 408 per study.
The research spans multiple phases of development: 8 studies are in NA, 7 studies are in PHASE2, 5 studies are in PHASE1, 3 studies are in PHASE3, 3 studies are in EARLY_PHASE1, 2 studies are in PHASE4. The presence of Phase 3 trials indicates that some pancreatitis treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 24 different organizations, including Johns Hopkins University, M.D. Anderson Cancer Center, University of Kansas Medical Center, Milton S. Hershey Medical Center, Anna Evans Phillips, and 19 others. The large number of sponsors reflects significant research interest and investment in pancreatitis treatment advancement.
Geographically, pancreatitis trials are most concentrated in Los Angeles, California (10 trials); Pittsburgh, Pennsylvania (10 trials); Baltimore, Maryland (9 trials); Indianapolis, Indiana (8 trials); Columbus, Ohio (7 trials) and 7 other cities.
Featured Pancreatitis Studies
Highlighted recruiting studies for pancreatitis, selected by enrollment size and research scope.
Rectal Indomethacin and Oral Tacrolimus Versus Combination to Prevent Post-ERCP Pancreatitis
This research is being done to see if using oral tacrolimus before endoscopy, can prevent pancreatitis that may occur after ERCP (a type of gastrointestinal endoscopy).
Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies
The Coordinating and Data Management Center (CDMC) at MD Anderson Cancer will be responsible for the coordination and data management for the Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies (PROCCEED) Study, which is part of the NIH U01 funded Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC). No patient enrollment ...
Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study
This clinical trial collects blood, saliva, urine, or stool samples to help identify possible genetic mutations that may increase a person's chance at developing pancreatic cancer. Finding genetic markers among pediatric patients with acute recurrent pancreatitis and chronic pancreatitis may help identify patients who are at risk of pancreatic cancer.
Frequently Asked Questions About Pancreatitis Clinical Trials
Are there pancreatitis clinical trials near me?
Yes, there are 37 pancreatitis clinical trials currently recruiting across 40+ cities in the United States, including Los Angeles, California; Pittsburgh, Pennsylvania; Baltimore, Maryland. Browse the studies above to find one at a location convenient for you.
How do I join a pancreatitis clinical trial?
To join a pancreatitis clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are pancreatitis clinical trials free?
Yes, participation in pancreatitis clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of pancreatitis treatments are being studied?
Current pancreatitis clinical trials are testing a range of approaches across NA (8 studies), PHASE2 (7 studies), PHASE1 (5 studies), PHASE3 (3 studies), EARLY_PHASE1 (3 studies), PHASE4 (2 studies). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 24 research organizations.
Is it safe to participate in pancreatitis clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 17, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 17, 2026 · Data from ClinicalTrials.gov